AZN
- NYSE - DRUGS - Drug Manufacturers - Major
Astrazeneca Plc Ads
|
$75.58 |
+1.05
1.40%
|
$75.83
|
$75.83
|
-0.34% |
2,674,235 59.57%
|
4,489,000
|
Most Recent Note for AZN - 4/21/2023 12:07:27 PM
Gapped up today matching its all-time high. Gapped up for a volume-driven gain on 4/18/23 when noted with caution in the mid-day report - "Reported Dec '22 quarterly earnings -19% on -7% sales revenues versus the year-ago period. Prior quarterly and annual earnings history does not match the fundamental guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BLD
- NYSE - Bldg-Constr Prds/Misc
Topbuild Corp
|
$221.99 |
+1.09
0.49%
|
$223.04
|
$225.82
|
-1.70% |
135,148 57.51%
|
235,000
|
Most Recent Note for BLD - 4/21/2023 12:08:35 PM
Rebounding toward its all-time high with today's 10th gain in the span of 11 sessions. Went through a deep consolidation from its high reached after it was dropped from the Featured Stocks list on 10/05/21.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BMI
- NYSE - Machinery-Constr/Mining
Badger Meter Inc
|
$135.12 |
+1.78
1.33%
|
$137.37
|
$138.12
|
-2.18% |
114,788 91.10%
|
126,000
|
Most Recent Note for BMI - 4/21/2023 12:12:26 PM
Gapped up on the prior session for a considerable volume-driven gain and a new all-time high. Reported Mar '23 quarterly earnings +35% on +20% sales revenues versus the year-ago period. Prior quarterly sales revenues and earnings history is not a match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CLMB
- NASDAQ - Wholesale-Electronics
Climb Global Solutions
|
$50.00 |
-1.50 -2.91%
|
$51.64
|
$55.70
|
-10.23% |
15,965 76.02%
|
21,000
|
Most Recent Note for CLMB - 4/21/2023 12:14:01 PM
Pulling back from its all-time high, encountering distributional pressure after a recent spurt of volume-driven gains. Reported Dec '22 quarterly earnings +36% on +18% sales revenues versus the year-ago period. Fundamental concerns remain after lower earnings versus the year ago for the Sep '22 quarter and lower sales revenues versus the year ago for the Jun '22 quarter.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HCA
- NYSE - HEALTH SERVICES - Hospitals
H C A Holdings Inc
|
$284.86 |
+14.08
5.20%
|
$294.02
|
$294.02
|
-3.12% |
2,127,680 177.16%
|
1,201,000
|
Most Recent Note for HCA - 4/21/2023 12:19:27 PM
Gapped up today hitting a new 52-week high with a considerable volume-driven gain. Reported earnings +20% for the Mar '23 quarter versus the year-ago period, and prior quarterly comparisons were below the +25% minimum earnings (C criteria) guideline. Annual earnings history included a downturn in FY '22. Completed Secondary Offerings on 12/12/12, 10/29/13, and 5/21/14. Has a new CEO as of 1/01/14.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$171.52 |
+6.15
3.72%
|
$172.00
|
$171.70
|
-0.10% |
830,340 61.78%
|
1,344,000
|
Most Recent Note for NVO - 4/21/2023 12:22:35 PM
This Denmark-based Medical - Ethical Drugs firm is hitting another new all-time high today, adding to previously noted volume-driven gains. Found prompt support after noted with caution in the 3/16/23 mid-day report when briefly undercutting its 50 DMA line - "Fundamental concerns remain. Reported Dec '22 quarterly earnings +19% on +18% sales revenues versus the year-ago period."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PCYG
- NASDAQ - Comp Sftwr-Spec Enterprs
Park City Group Inc
|
$6.80 |
+0.10
1.49%
|
$6.80
|
$6.75
|
0.74% |
8,602 50.60%
|
17,000
|
Most Recent Note for PCYG - 4/21/2023 12:23:59 PM
This thinly-traded Computer Software firm showed earnings increases above the +25% minimum guideline (C criteria) in 3 of the past for quarters through Dec '22 versus the year-ago periods. Quarterly sales revenues totals have been in the $4-5 million range, rather minuscule, and sales revenues growth has not been strong. Annual earnings included a downturn in FY '20.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
RUSHA
- NASDAQ - SPECIALTY RETAIL - Auto Dealerships
Rush Enterprises Cl A
|
$53.62 |
-0.98 -1.79%
|
$54.65
|
$62.20
|
-13.79% |
106,359 60.43%
|
176,000
|
Most Recent Note for RUSHA - 4/21/2023 12:26:24 PM
Reported earnings +47% on +44% sales revenues for the Dec '22 quarter versus the year-ago period. Prior quarterly comparisons were also above the +25% minimum earnings guideline (C criteria). Downturn in FY'19 and '20 earnings is a flaw in its annual earnings (A criteria) history with regard to the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SAIA
- NASDAQ - TRANSPORTATION - Trucking
Saia Inc
|
$280.20 |
+1.56
0.56%
|
$291.92
|
$306.40
|
-8.55% |
257,438 71.31%
|
361,000
|
Most Recent Note for SAIA - 4/21/2023 12:32:55 PM
Still faces resistance due to overhead supply up to the $365 level. Reported Dec '22 quarterly earnings -4% on +6% sales revenues versus the year-ago period, breaking a streak of 9 quarterly comparisons above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has improved following a downturn in FY '16.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SNA
- NYSE - MANUFACTURING - Small Tools & Accessories
Snap On Inc
|
$260.90 |
+2.01
0.77%
|
$262.06
|
$263.86
|
-1.12% |
173,888 56.09%
|
310,000
|
Most Recent Note for SNA - 4/21/2023 12:36:21 PM
Gapped up and hit new 52-week and all-time highs on the prior session with a considerable volume-driven gain. Reported earnings +15% on +8% sales revenues for the Mar '23 quarter versus the year-ago period. Prior quarters were not strong and steady above the +25% minimum earnings guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SNN
- NYSE - HEALTH SERVICES - Medical Appliances & Equipment
Smith & Nephew Plc Ads
|
$31.80 |
+0.88
2.85%
|
$31.81
|
$34.07
|
-6.66% |
542,879 59.27%
|
916,000
|
Most Recent Note for SNN - 4/21/2023 12:36:41 PM
Fundamental concerns remain. Annual earnings (A criteria_) history has been erratic and sales revenues have been flat for the 4 latest quarters through Dec '22 versus the year-ago periods.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
STLA
- NYSE - Auto Manufacturers
Stallantis NV
|
$17.52 |
-0.20 -1.10%
|
$17.57
|
$18.97
|
-7.67% |
3,039,987 54.55%
|
5,573,000
|
Most Recent Note for STLA - 4/21/2023 12:38:06 PM
Gapped down on the prior session, and slumping further today undercutting its 50 DMA line ($17.70). Prior mid-day reports noted - "Faces resistance due to overhead supply up to the $22 level following a deep consolidation. Fundamental concerns remain due to subpar quarterly and annual (C and A criteria) earnings history through Dec '22."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SWAV
- NASDAQ - Medical-Systems/Equip
Shockwave Medical
|
$281.00 |
+21.10
8.12%
|
$296.80
|
$320.54
|
-12.34% |
1,226,603 241.46%
|
508,000
|
Most Recent Note for SWAV - 4/21/2023 12:42:39 PM
Powering toward its 52-week high with today's considerable volume-driven gain. Resistance remains due to overhead supply up to the $320 level. Quarterly comparisons through Dec '22 showed very strong sales revenues and earnings increases over the year-ago periods. After years of losses it had a profitable FY '22, but its annual earnings history (A criteria) is not a match with the strict fundamental guidelines of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TRTN
- NYSE - Comml Svcs-Leasing
Triton International Ltd
|
$82.84 |
-0.16 -0.19%
|
$83.18
|
$83.82
|
-1.17% |
470,888 54.44%
|
865,000
|
Most Recent Note for TRTN - 4/21/2023 12:43:56 PM
Bermuda-based Container firm is stubbornly holding its ground following a gap up and considerable volume-driven gain for a new all-time high on 4/12/23. Went through a choppy consolidation above and below its 200 DMA line since noted with caution in the 7/28/22 mid-day report. Fundamental concerns remain. Reported Dec '22 quarterly earnings +3% on +0% sales revenues versus the year-ago period, its 2nd quarterly comparison below the +25% minimum earnings guideline (C criteria). Sequential quarterly comparisons show worrisome deceleration in its sales revenues growth rate and earnings. Completed a new Public Offering on 9/08/17.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WCN
- NYSE - MATERIALS & CONSTRUCTION - Waste Management
Waste Connections Inc
|
$144.61 |
+0.85
0.59%
|
$145.25
|
$148.20
|
-2.42% |
432,772 50.97%
|
849,000
|
Most Recent Note for WCN - 4/21/2023 12:46:11 PM
Recently wedging up toward its prior high and all-time high with gains lacking great volume conviction. Reported earnings +7% on +15% sales revenues for the quarter ended December 31, 2022 versus the year-ago period. Prior quarterly comparisons have not shown strong and steady earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) track record included a slight downturn in FY '20.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
XPO
- NYSE - Transportation-Logistics
X P O Logistics Inc
|
$43.66 |
+2.87
7.02%
|
$44.79
|
$45.06
|
-3.12% |
5,336,379 267.89%
|
1,992,000
|
Most Recent Note for XPO - 4/21/2023 12:52:56 PM
Rebounding near its February '23 high after a deep consolidation with today's 2nd consecutive big gap up and its 6th consecutive gain marked by ever-increasing volume. Faces resistance due to overhead supply up to the $53 level. Completed a new Public Offering on 6/29/21. Reported Dec '22 quarterly earnings +53% on +2% sales revenues versus the year-ago period. Fundamental concerns remain due to subpar sales revenues growth and its up-and-down annual earnings history (A criteria) that do not match with the fundamental guidelines of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|